Welcome to the world of Medicom

    Our Innovation strength becomes your competitiveness

We strive to be your preferred Innovation Partner within our business focus of Drug Delivery Devices and Connected Services – and we believe that our innovation strength becomes your competitiveness    

Morten Nielsen


Latest news 

  • Bayer received FDA approval

    for the BETACONNECT electronic autoinjector

    FDA approval for their BETACONNECT autoinjector for Multiple Sclerosis MORE

  • "We stay the SAME ...

    ... just with a NEW NAME

    Bang & Olufsen Medicom changes name to Medicom Innovation Partner MORE

  • Food for Thought

    Outcome is the new Income

    CEO Morten Nielsen explains the paradigm ahead MORE

  • B&O divests

    remaining shares in Medicom

    Bang & Olufsen have divested their remaining shares in Medicom to Maj Invest Equity MORE

  • Annual Report 2014

    Double-digit growth continues into 2014

    Our strong growth path from 2012 and 2013 continues in 2014 and confirms the strength and sustainability of our business. MORE